Skip to main content

Final Day to Save with the AIDS 2026 Early Registration Fee

February 12, 2026
Early registration for AIDS 2026 ends today, February 12. The Conference will take place July 26-31, 2026 in Rio de Janeiro, Brazil and virtually. This year’s theme will be Rethink. Rebuild. Rise. At a pivotal moment for HIV research and response—marked by unprecedented funding cuts and disruptions to HIV programs—the...

The UNC CFAR Honors National Black HIV/AIDS Awareness Day

February 5, 2026
Join the UNC CFAR and the NIH in honoring National Black HIV/AIDS Awareness Day on February 7th! Since 1999, this day has highlighted the importance of community engagement and improved access to HIV education, prevention, testing, and treatment services. While progress have been made in the areas of prevention, care,...

Respond Carolinas is Strengthening HIV Prevention and Care

January 29, 2026
Respond Carolinas is a community‑centered initiative aimed at improving HIV prevention, testing, and care engagement among Black and Latino men and transgender women in Charlotte, NC, and the surrounding area. The project is led by Ann Dennis, MD, MS, the principal investigator and an associate professor of infectious diseases at...

New Once Weekly HIV Oral Regimen Shows Strong Results after 48 Weeks

January 22, 2026
A phase 2 study, published in Annals of Internal Medicine and led by Joe Eron, MD, Director of the CFAR Clinical Core, found that a new once-weekly oral HIV treatment regimen achieved virologic suppression through 48 weeks. The study evaluated the efficacy and safety of once-weekly oral islatravir plus lenacapavir...

ACTG Launches IPACE-HIV to Study Frailty Intervention

January 15, 2026
The AIDS Clinical Trials Group (ACTG) has begun the IPACE-HIV study (Improving Physical Ability and Cellular Senescence Elimination in HIV). IPACE-HIV aims to evaluate the safety, tolerability, and efficacy of dasatinib and quercetin, medications that can help with reversing symptoms of frailty, in people living with HIV (PLWH), as well...

Landmark Findings from Study on a Tailored Implementation Approach Improves HIV Intervention for People Who Inject Drugs in Vietnam

January 8, 2026
UNC CFAR SBIS Core Director Vivian Go and Developmental Core Co-Director Bill Miller recently published the findings from their hybrid type 3 implementation-effectiveness, cluster-randomized trial in ten provinces in Vietnam. This study, conducted with a team from UNC Vietnam, Hanoi Medical University, and the Vietnam Ministry of Health, aimed to...

ID STEP Grant Award Will Build North Carolina’s Pipeline of Infectious Disease Specialists

December 18, 2025
Congratulations to the UNC Institute for Global Health and Infectious Diseases for being awarded an ID STEP (Infectious Disease Structured Training and Engagement Program) grant. This grant will be used to develop a program for medical students to expand equitable access to infectious disease expertise for folks living in North...

M-HIRST Grant Renewal Demonstrates Growth and Leadership

November 20, 2025
The UNC CFAR congratulates the Malawi HIV Implementation Research Scientist Training (M-HIRST) program, which was competitively renewed with partners at Kamuzu University of Health Sciences (KUHeS). This program is funded by the Fogarty International Center at the U.S. National Institutes of Health (NIH). The M-HIRST program will continue to strengthen...

Exploring Goals and Values

November 11, 2025
When we ask the client what matters most to them, it can be a good way to continue building rapport. This conversation can explore what the client really cares about and how these goals and values may guide their lives. And we also know that goals and values are aspirations,...